HARV2

PROJECT HIGHLIGHTS

Rehabilitation prognosis

Identification of brain recovery biomarkers that can be monitored during therapy, inform therapy adjustments, and advance our ability to predict stroke recovery outcome.

Multi-technological approach

State of the art neuroimaging, MR-compatible robotics, serious gaming are combined with clinical monitoring in a novel rehabilitation approach.

Top partners

NMR Surgical Laboratory of the Massachusetts General Hospital/ Harvard Medical School and Athinoula A. Martinos Center for Biomedical Imaging are world-class partners participating in the project.

NIH grant award

This project is supported by a grant from the National Institute of Neurological Disorders and Stroke (Grant number 1R01NS105875-01A1) of the National Institutes of Health to A. Aria Tzika.

SKILLS AND TECHNOLOGY

QBase will provide consultation services (Data analysis and modelling) using state of the art neuroimaging data (fMRI, DTI, 3D Volumetrics) and methods (GLM, DCM, TBSS, Graph theory, DARTEL, Surface analysis) as well as robotic device outputs, serious game score elements and clinical data. Prognostic models will be constructed using standard statistical tools (i.e. Generalized equation modelling) and machine learning approaches.

SOME DETAILS

Stroke is a major cause of morbidity and invalidity in modern society. A novel Magnetic Resonance Compatible Hand Robotic Device combined with state-of-the-art in vivo magnetic resonance imaging of brain structure and function will provide biomarkers that can be used to evaluate and predict the effects of training on the motor skills and brain recovery of stroke patients. The findings will advance stroke recovery research, which has been hampered from the longstanding view that lost functions were not recoverable and may ultimately contribute to improving the quality of life of stroke patients especially in the elderly where stroke is more prevalent.

Category: Επεξεργασία Σημάτων